Hungary’s decision to reopen the debate on treating new generation GM plants as equivalent to conventional crops threatens to delay the agrotech industry’s hopes for easing regulations. The Hungarian presidency’s stance clashes with the European Food Safety Authority’s (EFSA) scientific opinion, which supports the equivalence of certain GM crops to conventionally bred plants. The debate raises concerns about risk assessment, patenting, and potential monopolies, with advocates and opponents highlighting their respective perspectives.